Baird Financial Group, Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,763,000
+6.9%
36,747
+2.5%
0.01%
-12.5%
Q1 2020$1,649,000
-23.2%
35,837
+0.2%
0.01%0.0%
Q4 2019$2,148,000
+20.0%
35,749
+13.0%
0.01%
+14.3%
Q3 2019$1,790,000
+5.6%
31,642
+4.0%
0.01%0.0%
Q2 2019$1,695,000
+4.6%
30,432
-5.2%
0.01%
-22.2%
Q1 2019$1,620,000
+17.7%
32,085
-6.1%
0.01%0.0%
Q4 2018$1,376,000
-40.7%
34,164
-0.3%
0.01%
-40.0%
Q3 2018$2,320,000
-9.2%
34,251
+1.4%
0.02%
-11.8%
Q2 2018$2,554,000
+43.7%
33,762
+0.1%
0.02%
+30.8%
Q1 2018$1,777,000
-1.1%
33,718
+0.3%
0.01%0.0%
Q4 2017$1,796,000
-10.7%
33,613
-0.3%
0.01%
-13.3%
Q3 2017$2,011,000
-24.8%
33,717
-0.5%
0.02%
-28.6%
Q2 2017$2,673,000
-5.1%
33,887
-0.3%
0.02%
-8.7%
Q1 2017$2,818,000
+5.9%
33,973
+1.3%
0.02%0.0%
Q4 2016$2,660,00033,5220.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders